Antibiotic Prophylaxis in Reduction Mammaplasty: A National Survey.


Journal

Aesthetic plastic surgery
ISSN: 1432-5241
Titre abrégé: Aesthetic Plast Surg
Pays: United States
ID NLM: 7701756

Informations de publication

Date de publication:
10 2022
Historique:
received: 28 12 2021
accepted: 03 04 2022
pubmed: 11 5 2022
medline: 27 10 2022
entrez: 10 5 2022
Statut: ppublish

Résumé

Although there is limited evidence for regulating the use of prophylactic antibiotics in reduction mammaplasty, many plastic surgeons prescribe them, even in the postoperative period. This study aimed to conduct a national survey to investigate the antibiotic prophylaxis protocols followed by Brazilian plastic surgeons in reduction mammaplasty. An anonymous survey comprising 19 questions was sent to all 4864 active members of the Brazilian Society of Plastic Surgery (SBCP). The surgeons electronically received the invitation to participate in the survey and the link to fill out the electronic form. In total, 859 surgeons (17.7%) responded. Most respondents (77.8%) were men and aged 35-55 years (61.5%); 58.6% of them had 10-29 years of specialty training. Only a minor proportion of the respondents (0.5%) reported not prescribing antibiotics at any time (95% confidence interval [CI]: 0.0-0.9), 9.9% (95% CI: 7.9-11.9) prescribed them only preoperatively, and 14.6% (95% CI: 12.2-16.9) prescribed continued antibiotic use for 24 h. The majority of the respondents (75.1%; 95% CI: 72.1-77.9) prescribed antibiotics for additional days after discharge. There were significant associations between antibiotic prescription and the surgeons' age group (p = 0.015), time since graduation (p < 0.001), experience in the specialty practice (p = 0.003), SBCP membership (p < 0.001), and surgical site infection rates (p = 0.011). Most responding plastic surgeons affirmed that they prescribed prophylactic antibiotics for more than 24 h in reduction mammaplasty cases. This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Sections du résumé

BACKGROUND
Although there is limited evidence for regulating the use of prophylactic antibiotics in reduction mammaplasty, many plastic surgeons prescribe them, even in the postoperative period. This study aimed to conduct a national survey to investigate the antibiotic prophylaxis protocols followed by Brazilian plastic surgeons in reduction mammaplasty.
METHODS
An anonymous survey comprising 19 questions was sent to all 4864 active members of the Brazilian Society of Plastic Surgery (SBCP). The surgeons electronically received the invitation to participate in the survey and the link to fill out the electronic form.
RESULTS
In total, 859 surgeons (17.7%) responded. Most respondents (77.8%) were men and aged 35-55 years (61.5%); 58.6% of them had 10-29 years of specialty training. Only a minor proportion of the respondents (0.5%) reported not prescribing antibiotics at any time (95% confidence interval [CI]: 0.0-0.9), 9.9% (95% CI: 7.9-11.9) prescribed them only preoperatively, and 14.6% (95% CI: 12.2-16.9) prescribed continued antibiotic use for 24 h. The majority of the respondents (75.1%; 95% CI: 72.1-77.9) prescribed antibiotics for additional days after discharge. There were significant associations between antibiotic prescription and the surgeons' age group (p = 0.015), time since graduation (p < 0.001), experience in the specialty practice (p = 0.003), SBCP membership (p < 0.001), and surgical site infection rates (p = 0.011).
CONCLUSION
Most responding plastic surgeons affirmed that they prescribed prophylactic antibiotics for more than 24 h in reduction mammaplasty cases.
LEVEL OF EVIDENCE V
This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

Identifiants

pubmed: 35538245
doi: 10.1007/s00266-022-02903-w
pii: 10.1007/s00266-022-02903-w
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2124-2130

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2022. Springer Science+Business Media, LLC, part of Springer Nature and International Society of Aesthetic Plastic Surgery.

Références

International Society of Aesthetic Plastic Surgery. ISAPS international survey on aesthetic/cosmetic procedures. https://www.isaps.org/wp-content/uploads/2020/12/Global-Survey-2019.pdf . Accessed 27 Dec 2021
Zapata-Copete J, Aguilera-Mosquera S, García-Perdomo HA (2017) Antibiotic prophylaxis in breast reduction surgery: a systematic review and meta-analysis. J Plast Reconstr Aesthet Surg 70:1689–1695
doi: 10.1016/j.bjps.2017.08.005
Vieira LFDF, De Melo Neto AF, Schio MR, De Oliveira JAV, Almeida CLA, Ferraz AAB (2016) Controversies in reduction mammoplasty: Being a “clean” operation, does it mandate antibiotic prophylaxis? Surg Infect 17:596–600
doi: 10.1089/sur.2016.072
Vazquez-Aragon P, Lizan-Garcia M, Cascales-Sanchez P, Villar-Canovas MT, Garcia-Olmo D (2003) Nosocomial infection and related risk factors in a general surgery service: a prospective study. J Infect 46:17–22
doi: 10.1053/jinf.2002.1073
Bartsich S, Ascherman JA, Whittier S, Yao CA, Rohde C (2011) The breast: a clean-contaminated surgical site. Aesthet Surg J 31:802–806
doi: 10.1177/1090820X11417428
Ahmadi AH, Cohen BE, Shayani P (2005) A prospective study of antibiotic efficacy in preventing infection in reduction mammaplasty. Plast Reconst Surg 116:126–131
doi: 10.1097/01.PRS.0000169719.10060.32
Veiga-Filho J, Veiga DF, Neto MS, Amorim MC, Novo NF, Ferreira LM (2010) The role of antibiotics in reduction mammaplasty. Ann Plast Surg 65:144–146
doi: 10.1097/SAP.0b013e3181c47d88
Shortt R, Cooper MJ, Farrokhyar F, Bain J (2014) Meta-analysis of antibiotic prophylaxis in breast reduction surgery. Plast Surg 22:91–94
doi: 10.1177/229255031402200211
Berríos-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, Reinke CE, Morgan S, Solomkin JS, Mazuski JE, Dellinger EP, Itani KMF, Berbari EF, Segreti J, Parvizi J, Blanchard J, Allen G, Kluytmans JAJW, Donlan R, Schecter WP, Committee HICPA (2017) Centers for disease control and prevention guideline for the prevention of surgical site infection, 2017. JAMA Surg 152:784
doi: 10.1001/jamasurg.2017.0904
Kalliainen LK (2012) ASPS clinical practice guideline summary on reduction mammaplasty. Plast Reconstr Surg 130:785–789
doi: 10.1097/PRS.0b013e318262f0c0
Hardwicke JT, Bechar J, Skillman JM (2013) Are systemic antibiotics indicated in aesthetic breast surgery? A systematic review of the literature. Plast Reconstr Surg 131:1395–1403
doi: 10.1097/PRS.0b013e31828bd752
Lundberg J, Thorarinsson A, Elander A, Lidén M, Lewin R, Göransson M (2013) Risk factors for complications after breast reduction surgery. J Plast Surg Hand Surg 48:10–14
pubmed: 23627557
Veiga DF, da Silva GE, Moreira-Filho JW, de Mattos Andrade EB, Juliano Y, Veiga-Filho J, Ferreira LM (2020) Single dose versus 24 h antibiotic prophylaxis in reduction mammaplasty: study protocol for a randomized controlled trial. Trials 21:1–9
doi: 10.1186/s13063-020-04539-0
Boccara D, Couteau C, Chaouat M, Mimoun M, Serror K (2018) Antibiotic prophylaxis in breast reduction surgery: a different approach. J Plast Reconstr Aesthet Surg 71:435–436
doi: 10.1016/j.bjps.2017.09.014
Liu DZ, Dubbins JA, Louie O, Said HK, Neligan PC, Mathes DW (2012) Duration of antibiotics after microsurgical breast reconstruction does not change surgical infection rate. Plast Reconstr Surg 129:362–367
doi: 10.1097/PRS.0b013e31823ae8ce
Sajid MS, Hutson K, Akhter N, Kalra L, Rapisarda IF, Bonomi R (2012) An updated meta-analysis on the effectiveness of preoperative prophylactic antibiotics in patients undergoing breast surgical procedures. Breast J 18:312–317
doi: 10.1111/j.1524-4741.2012.01248.x
Kerrigan CL, Slezak SS (2013) Evidence-based medicine: reduction mammaplasty. Plast Reconstr Surg 132:1670–1683
doi: 10.1097/PRS.0b013e3182a807ec
Greco R, Noone B (2017) Evidence-based medicine: reduction mammaplasty. Plast Reconstr Surg 139:230e–239e
doi: 10.1097/PRS.0000000000002856
Clayton JL, Bazakas A, Lee CN, Hultman CS, Halvorson EG (2012) Once is not enough: withholding postoperative prophylactic antibiotics in prosthetic breast reconstruction is associated with an increased risk of infection. Plast Reconstr Surg 130:495–502
doi: 10.1097/PRS.0b013e31825dbefe
Crawford CB, Clay JA, Seydel AS, Wernberg JA (2016) Surgical site infections in breast surgery: the use of preoperative antibiotics for elective, nonreconstructive procedures. Int J Breast Cancer 2016:1–7
doi: 10.1155/2016/1645192
Garcia ES, Veiga DF, Veiga-Filho J, Cabral IV, Pinto NLL, Novo NF, Sabino-Neto M, Ferreira LM (2020) Postoperative antibiotic prophylaxis in reduction mammaplasty: a randomized controlled trial. Plast Reconstr Surg 145(6):1022e–1028e
doi: 10.1097/PRS.0000000000006809
Okoro SA, Barone C, Bohnenblust M, Wang HT (2008) Breast reduction trend among plastic surgeons: a national survey. Plast Reconstr Surg 122:1312–1320
doi: 10.1097/PRS.0b013e3181881dd7
Peled IJ, Dvir G, Berger J, Ramon I, Ullmann Y, Nachlieli T (2000) Prophylactic antibiotics in aesthetic and reconstructive surgery. Aesth Plast Surg 24:299–302
doi: 10.1007/s002660010050
Iwuagwu OC, Platt AJ, Drew PJ (2006) Breast reduction surgery in the UK and Ireland—current trends. Ann R Coll Surg Engl 88:585–588
doi: 10.1308/003588406X130598
Young PY, Khadaroo RG (2014) Surgical site infections. Surg Clin North Am 94:1245–1264
doi: 10.1016/j.suc.2014.08.008
Ariyan S, Martin J, Lal A, Cheng D, Borah GL, Chung KC, Conly J, Havlik R, Lee WPA, McGrath MH, Pribaz J, Young VL (2015) Antibiotic prophylaxis for preventing surgical-site infection in plastic surgery: an evidence-based consensus conference statement from the American Association of Plastic Surgeons. Plast Reconstr Surg 135:1723–1739
doi: 10.1097/PRS.0000000000001265
DeBono R (1998) Problem encountered in a questionnaire-based study intended to investigate the use of prophylactic antibiotics by plastic surgeons in the UK. Br J Plast Surg 51:569
pubmed: 9924416

Auteurs

Ricardo Beckhauser Kuhnen (RB)

Translational Surgery Graduate Program, Universidade Federal de Sao Paulo, Rua Botucatu, 740, 2º andar. Vila Clementino, São Paulo, SP, Brazil.

Miguel Sabino Neto (M)

Translational Surgery Graduate Program, Universidade Federal de Sao Paulo, Rua Botucatu, 740, 2º andar. Vila Clementino, São Paulo, SP, Brazil.

Lucas Vassalli Souza (LV)

School of Medicine, Universidade Federal de Sao Paulo, Sao Paulo, SP, Brazil.

Lydia Masako Ferreira (LM)

Translational Surgery Graduate Program, Universidade Federal de Sao Paulo, Rua Botucatu, 740, 2º andar. Vila Clementino, São Paulo, SP, Brazil.

Daniela Francescato Veiga (DF)

Translational Surgery Graduate Program, Universidade Federal de Sao Paulo, Rua Botucatu, 740, 2º andar. Vila Clementino, São Paulo, SP, Brazil. danielafveiga@gmail.com.
Division of Plastic Surgery, Universidade do Vale do Sapucaí, Pouso Alegre, MG, Brazil. danielafveiga@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH